Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lasagna

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|February 28, 1975
Report of a workshop on fixed-ratio drug combinationsH J Dengler, L Lasagna
Clinical Pharmacology and Therapeutics|March 1, 1983
A comparison of drug product information in four national compendiaJ L Alloza, L Lasagna
Journal of Clinical Pharmacology|August 1, 1994
A white paper on the appropriateness of proposals by the FDA to modify labeling of benzodiazepine sedative-hypnoticsL Lasagna, R I Shader
The New England Journal of Medicine|June 19, 1986
More than skin deep: transdermal drug-delivery systemsL Lasagna, D J Greenblatt
Annals of Internal Medicine|June 1, 1987
Drug regulation in the United States and the United Kingdom: the Depo-Provera storyB W Richard, L Lasagna
JAMA|April 14, 1975
Commentary: the FDA, politics, and the publicL Lasagna, W M Wardell
IRB|March 9, 2002
Demystifying central review boards: current options and future directionsR J Levine, L Lasagna
Clinical Pharmacology and Therapeutics|August 1, 1985
Oral ciramadol in the treatment of postoperative painL Lasagna, J F Calimlim
Journal of Clinical Pharmacology|May 1, 1988
Anorectic drugs: drug policy making at the state levelB W Richard, L Lasagna
Science (New York, N.Y.)|December 29, 1998
Issues facing the new FDA commissionerL Lasagna, K I Kaitin
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|February 28, 1975
Report of a workshop on fixed-ratio drug combinationsH J Dengler, L Lasagna
Clinical Pharmacology and Therapeutics|March 1, 1983
A comparison of drug product information in four national compendiaJ L Alloza, L Lasagna
Journal of Clinical Pharmacology|August 1, 1994
A white paper on the appropriateness of proposals by the FDA to modify labeling of benzodiazepine sedative-hypnoticsL Lasagna, R I Shader
The New England Journal of Medicine|June 19, 1986
More than skin deep: transdermal drug-delivery systemsL Lasagna, D J Greenblatt
Annals of Internal Medicine|June 1, 1987
Drug regulation in the United States and the United Kingdom: the Depo-Provera storyB W Richard, L Lasagna
JAMA|April 14, 1975
Commentary: the FDA, politics, and the publicL Lasagna, W M Wardell
IRB|March 9, 2002
Demystifying central review boards: current options and future directionsR J Levine, L Lasagna
Clinical Pharmacology and Therapeutics|August 1, 1985
Oral ciramadol in the treatment of postoperative painL Lasagna, J F Calimlim
Journal of Clinical Pharmacology|May 1, 1988
Anorectic drugs: drug policy making at the state levelB W Richard, L Lasagna
Science (New York, N.Y.)|December 29, 1998
Issues facing the new FDA commissionerL Lasagna, K I Kaitin
Pageof 20